{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:50:42Z","timestamp":1785682242341,"version":"3.56.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1097\/pas.0000000000000505","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T13:14:35Z","timestamp":1439471675000},"page":"1282-1289","source":"Crossref","is-referenced-by-count":31,"title":["GATA3 Immunohistochemistry Expression in Histologic Subtypes of Primary Breast Carcinoma and Metastatic Breast Carcinoma Cytology"],"prefix":"10.1097","volume":"39","author":[{"given":"Georgios","family":"Deftereos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Sanguino Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan F.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Krishnamurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210131","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/384474a0","article-title":". Transcription factor GATA-3 is required for development of the T-cell lineage.","volume":"384","author":"Ting","year":"1996","journal-title":"Nature"},{"key":"R2-15-20210131","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1128\/MCB.11.5.2778","article-title":". Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer.","volume":"11","author":"Ko","year":"1991","journal-title":"Mol Cell Biol"},{"key":"R3-15-20210131","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jcp.21943","article-title":"GATA3 in development and cancer differentiation: cells GATA have it!.","volume":"222","author":"Chou","year":"2010","journal-title":"J Cell Physiol"},{"key":"R4-15-20210131","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/1947601911404223","article-title":"GATA transcription factors and cancer.","volume":"1","author":"Zheng","year":"2010","journal-title":"Genes Cancer"},{"key":"R5-15-20210131","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1101\/gad.1115203","article-title":". GATA-3: an unexpected regulator of cell lineage determination in skin.","volume":"17","author":"Kaufman","year":"2003","journal-title":"Genes Dev"},{"key":"R6-15-20210131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-0560.2009.01416.x","article-title":"Expression pattern of GATA-3 in embryonic and fetal human skin suggests a role in epidermal and follicular morphogenesis.","volume":"37","author":"Sellheyer","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R7-15-20210131","doi-asserted-by":"crossref","first-page":"28729","DOI":"10.1074\/jbc.M109.016840","article-title":". GATA3 is selectively expressed in the trophectoderm of peri-implantation embryo and directly regulates Cdx2 gene expression.","volume":"284","author":"Home","year":"2009","journal-title":"J Biol Chem"},{"key":"R8-15-20210131","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2006.09.048","article-title":". GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.","volume":"127","author":"Kouros-Mehr","year":"2006","journal-title":"Cell"},{"key":"R9-15-20210131","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb1530","article-title":". Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation.","volume":"9","author":"Asselin-Labat","year":"2007","journal-title":"Nat Cell Biol"},{"key":"R10-15-20210131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":". Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas.","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R11-15-20210131","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PAP.0b013e3182a28a68","article-title":"Value of GATA3 immunostaining in tumor diagnosis: a review.","volume":"20","author":"Ordonez","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R12-15-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":". GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R13-15-20210131","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.pas.0000213438.01278.5f","article-title":". Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.","volume":"31","author":"Higgins","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R14-15-20210131","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PAS.0b013e3181908e24","article-title":". Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.","volume":"33","author":"Esheba","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R15-15-20210131","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.humpath.2010.11.011","article-title":". Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.","volume":"42","author":"Raspollini","year":"2011","journal-title":"Hum Pathol"},{"key":"R16-15-20210131","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1582-4934.2010.01019.x","article-title":". Gene expression signatures differentiate ovarianperitoneal serous carcinoma from breast carcinoma in effusions.","volume":"15","author":"Davidson","year":"2011","journal-title":"J Cell Mol Med"},{"key":"R17-15-20210131","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S","article-title":". GATA-3 is expressed in association with estrogen receptor in breast cancer.","volume":"84","author":"Hoch","year":"1999","journal-title":"Int J Cancer"},{"key":"R18-15-20210131","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.humpath.2008.09.010","article-title":". The significance of GATA3 expression in breast cancer: a 10-year follow-up study.","volume":"40","author":"Ciocca","year":"2009","journal-title":"Hum Pathol"},{"key":"R19-15-20210131","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/bcr2249","article-title":". Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.","volume":"11","author":"Jacquemier","year":"2009","journal-title":"Breast Cancer Res"},{"key":"R20-15-20210131","first-page":"774","article-title":". Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.","volume":"15","author":"Demir","year":"2010","journal-title":"J BUON"},{"key":"R21-15-20210131","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1055-9965.EPI-06-1090","article-title":"GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.","volume":"17","author":"Voduc","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-15-20210131","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.humpath.2014.06.022","article-title":". Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer.","volume":"45","author":"Krings","year":"2014","journal-title":"Hum Pathol"},{"key":"R23-15-20210131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dc.23206","article-title":"Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.","volume":"43","author":"Braxton","year":"2014","journal-title":"Diagn Cytopathol"},{"key":"R24-15-20210131","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/PAI.0b013e318297cc0b","article-title":". In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 cases.","volume":"22","author":"Kawaguchi","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R26-15-20210131","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.humpath.2012.11.003","article-title":". GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.","volume":"44","author":"Cimino-Mathews","year":"2013","journal-title":"Hum Pathol"},{"key":"R27-15-20210131","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1309\/AJCP0Q9UQTEESLHN","article-title":". Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas.","volume":"141","author":"Liu","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R28-15-20210131","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.humpath.2014.03.006","article-title":"Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.","volume":"45","author":"Ordonez","year":"2014","journal-title":"Hum Pathol"},{"key":"R29-15-20210131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncy.21393","article-title":"GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.","volume":"122","author":"Shield","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"R30-15-20210131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1309\/AJCP8H2VBDSCIOBF","article-title":". Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas.","volume":"142","author":"Clark","year":"2014","journal-title":"Am J Clin Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:45:33Z","timestamp":1620967533000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201509000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000505","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}